BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/15/2014 5:09:00 PM | Browse: 1531 | Download: 1394
 |
Received |
|
2013-03-21 11:11 |
|
Peer-Review Started |
|
2013-03-21 12:52 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2013-04-17 10:09 |
|
Revised |
|
|
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2013-06-03 16:06 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2013-06-04 09:40 |
|
Articles in Press |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2013-06-09 13:10 |
|
Publish the Manuscript Online |
|
2013-06-20 00:12 |
| Category |
Rheumatology |
| Manuscript Type |
Editorial |
| Article Title |
B cell depletion in scleroderma lung disease: A promising new treatment?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Dimitrios Daoussis and Andrew P Andonopoulos |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Dr. Dimitrios Daoussis, MD, Division of Rheumatology, Department of Internal Medicine, Patras University Hospital, University of Patras Medical School, Rion, 26504 Patras, Greece. jimdaoussis@hotmail.com
|
| Key Words |
Rituximab; Scleroderma; Systemic sclerosis; Interstitial lung disease; Treatment |
| Core Tip |
Rituximab (RTX) may be an effective treatment for systemic sclerosis (SSc)-associated interstitial lung disease (ILD). A large scale study assessing the efficacy of RTX in SSc associated ILD is warranted. If RTX turns out to be effective, it would be a major therapeutic advance in SSc since it can be administered on a long term basis due to its acceptable safety profile. |
| Publish Date |
2013-06-20 00:12 |
| Citation |
Daoussis D, Andonopoulos AP. B cell depletion in scleroderma lung disease: A promising new treatment? World J Rheumatol 2013; 3(2): 9-11 |
| URL |
http://www.wjgnet.com/2220-3214/full/v3/i2/9.htm |
| DOI |
http://dx.doi.org/10.5499/wjr.v3.i2.9 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
